Cheryl
Wellington

Dr. Cheryl Wellington is Professor in the Department of Pathology and Laboratory Medicine, Djavad Mowafaghian Center for Brain Health at the University of British Columbia. She is also Principal Investigator at the International Collaboration on Repair Discoveries at Vancouver General Hospital and Associate Member of the UBC School of Biomedical Engineering. Dr. Wellington’s research interests are highly multidisciplinary with major efforts in Alzheimer’s Disease (AD) and Traumatic Brain Injury (TBI). With respect to both AD and TBI programs, her laboratory is the leading Canadian site for research on blood biomarkers using the Quanterix single molecule array (Simoa) platform. Her work on AD focuses mainly on how lipoproteins affect AD pathogenesis, with major projects focused on apolipoprotein E (apoE). For the AD program, her laboratory uses animal models and in vitro platforms, including pioneering a human-based 3D tissue engineered model of perfusable cerebral vessels. Along with Dr. Peter Cripton, a Mechanical Engineer, Dr. Wellington developed the CHIMERA (Closed Head Model of Engineered Rotational Acceleration) animal model of TBI. Dr. Wellington is now also leading efforts to understand the neurological consequences of COVID-19. Dr. Wellington holds multiple leadership positions in both the dementia and neurotrauma communities.